Sorafenib Overcomes Irinotecan Resistance in Colorectal Cancer by Inhibiting the ABCG2 Drug-Efflux Pump

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-12-0966
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Bafetinib (INNO-406) Reverses Multidrug Resistance by Inhibiting the Efflux Function of ABCB1 and ABCG2 Transporters

Scientific Reports
Multidisciplinary
2016English

Gambogic Acid Inhibits Growth, Induces Apoptosis, and Overcomes Drug Resistance in Human Colorectal Cancer Cells

International Journal of Oncology
Cancer ResearchOncology
2015English

Drug Efflux Pump Expression in 50,000 Molecularly-Profiled Cancer Patients.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2015English

Chrysin Overcomes TRAIL Resistance of Cancer Cells Through McL-1 Downregulation by Inhibiting STAT3 Phosphorylation

International Journal of Oncology
Cancer ResearchOncology
2013English

RhoA Regulates Resistance to Irinotecan by Regulating Membrane Transporter and Apoptosis Signaling in Colorectal Cancer

Oncotarget
Oncology
2016English

TARBP2-mediated Destabilization of Nanog Overcomes Sorafenib Resistance in Hepatocellular Carcinoma

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2019English

Neoadjuvant Endocrine Therapy in Breast Cancer Up-Regulates the Cytotoxic Drug Pump ABCG2 /BCRP, and May Lead to Resistance to Subsequent Chemotherapy

Clinical Breast Cancer
Cancer ResearchOncology
2018English

Bevacizumab May Overcome Clinical Tumor Drug Resistance to Irinotecan Based Chemotherapy in Patients With Metastatic Colorectal Cancer: Case Report

The Open Colorectal Cancer Journal
2010English

FL118, a Novel Camptothecin Derivative, Is Insensitive to ABCG2 Expression and Shows Improved Efficacy in Comparison With Irinotecan in Colon and Lung Cancer Models With ABCG2-induced Resistance

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy